AAAAAA

   
Results: 1-10 |
Results: 10
ADVANTAGES OF TIME-BASED NEW PRODUCT DEVELOPMENT IN A FAST-CYCLE INDUSTRY
Authors: DATAR S JORDAN CC KEKRE S RAJIV S SRINIVASAN K
Citation: S. Datar et al., ADVANTAGES OF TIME-BASED NEW PRODUCT DEVELOPMENT IN A FAST-CYCLE INDUSTRY, Journal of marketing research, 34(1), 1997, pp. 36-49
TOWARDS UNDERSTANDING THE ETIOLOGY AND PATHOPHYSIOLOGY OF THE EMETIC REFLEX - NOVEL APPROACHES TO ANTIEMETIC DRUGS
Authors: BOUNTRA C GALE JD GARDNER CJ JORDAN CC KILPATRICK GJ TWISSELL DJ WARD P
Citation: C. Bountra et al., TOWARDS UNDERSTANDING THE ETIOLOGY AND PATHOPHYSIOLOGY OF THE EMETIC REFLEX - NOVEL APPROACHES TO ANTIEMETIC DRUGS, Oncology, 53, 1996, pp. 102-109
THE ACTION OF THE NK1 TACHYKININ RECEPTOR ANTAGONIST, CP-99,994, IN ANTAGONIZING THE ACUTE AND DELAYED EMESIS INDUCED BY CISPLATIN IN THE FERRET
Authors: RUDD JA JORDAN CC NAYLOR RJ
Citation: Ja. Rudd et al., THE ACTION OF THE NK1 TACHYKININ RECEPTOR ANTAGONIST, CP-99,994, IN ANTAGONIZING THE ACUTE AND DELAYED EMESIS INDUCED BY CISPLATIN IN THE FERRET, British Journal of Pharmacology, 119(5), 1996, pp. 931-936
ROLE OF PEPSIN IN THE DEVELOPMENT OF INDOMETHACIN-INDUCED ANTRAL ULCERATION IN THE RAT
Authors: GAW AJ WILLIAMS LV SPRAGGS CF JORDAN CC
Citation: Aj. Gaw et al., ROLE OF PEPSIN IN THE DEVELOPMENT OF INDOMETHACIN-INDUCED ANTRAL ULCERATION IN THE RAT, Alimentary pharmacology & therapeutics, 9(2), 1995, pp. 167-172
THE BROAD-SPECTRUM ANTIEMETIC ACTIVITY OF THE NOVEL NONPEPTIDE TACHYKININ NK1 RECEPTOR ANTAGONIST GR203040
Authors: GARDNER CJ TWISSELL DJ DALE TJ GALE JD JORDAN CC KILPATRICK GJ BOUNTRA C WARD P
Citation: Cj. Gardner et al., THE BROAD-SPECTRUM ANTIEMETIC ACTIVITY OF THE NOVEL NONPEPTIDE TACHYKININ NK1 RECEPTOR ANTAGONIST GR203040, British Journal of Pharmacology, 116(8), 1995, pp. 3158-3163
EVOLUTION OF A NOVEL SERIES OF [(N,N-DIMETHYLAMINO)PROPYL]ANILIDE ANDPIPERAZINYLBENZANILIDES AS THE FIRST SELECTIVE 5-HT1D ANTAGONISTS
Authors: CLITHEROW JW SCOPES DIC SKINGLE M JORDAN CC FENIUK W CAMPBELL IB CARTER MC COLLINGTON EW CONNOR HE HIGGINS GA BEATTIE D KELLY HA MITCHELL WL OXFORD AW WADSWORTH AH TYERS MB
Citation: Jw. Clitherow et al., EVOLUTION OF A NOVEL SERIES OF [(N,N-DIMETHYLAMINO)PROPYL]ANILIDE ANDPIPERAZINYLBENZANILIDES AS THE FIRST SELECTIVE 5-HT1D ANTAGONISTS, Journal of medicinal chemistry, 37(15), 1994, pp. 2253-2257
PROFILES OF EMETIC ACTION OF CISPLATIN IN THE FERRET - A POTENTIAL MODEL OF ACUTE AND DELAYED EMESIS
Authors: RUDD JA JORDAN CC NAYLOR RJ
Citation: Ja. Rudd et al., PROFILES OF EMETIC ACTION OF CISPLATIN IN THE FERRET - A POTENTIAL MODEL OF ACUTE AND DELAYED EMESIS, European journal of pharmacology, 262(1-2), 1994, pp. 180000001-180000002
ANTIEMETIC ACTIVITY OF NEUROKININ NK1 RECEPTOR ANTAGONISTS IS MEDIATED CENTRALLY IN THE FERRET
Authors: GARDNER CJ BOUNTRA C BUNCE KT DALE TJ JORDAN CC TWISSELL DJ WARD P
Citation: Cj. Gardner et al., ANTIEMETIC ACTIVITY OF NEUROKININ NK1 RECEPTOR ANTAGONISTS IS MEDIATED CENTRALLY IN THE FERRET, British Journal of Pharmacology, 112, 1994, pp. 210000046-210000046
LOW-MOLECULAR-WEIGHT NEUROKININ-NK(2) ANTAGONISTS
Authors: SMITH PW MCELROY AB PRITCHARD JM DEAL MJ EWAN GB HAGAN RM IRELAND SJ BALL D BERESFORD I SHELDRICK R JORDAN CC WARD P
Citation: Pw. Smith et al., LOW-MOLECULAR-WEIGHT NEUROKININ-NK(2) ANTAGONISTS, Bioorganic & medicinal chemistry letters, 3(5), 1993, pp. 931-936
SYNTHESIS OF A POTENT ANTAGONIST OF SUBSTANCE-P BY REPLACING THE CH2SCH3 AND THE ALPHA-CARBOXAMIDE GROUPS OF THE METHIONINE AT [ORN6]-SP(6-11) BY BENZYL ESTER GROUPS
Authors: KARAGIANNIS K STAVROPOULOS G POULOS C JORDAN CC HAGAN RM
Citation: K. Karagiannis et al., SYNTHESIS OF A POTENT ANTAGONIST OF SUBSTANCE-P BY REPLACING THE CH2SCH3 AND THE ALPHA-CARBOXAMIDE GROUPS OF THE METHIONINE AT [ORN6]-SP(6-11) BY BENZYL ESTER GROUPS, International journal of peptide & protein research, 42(6), 1993, pp. 565-569
Risultati: 1-10 |